Increased plasma levels of sRAGE are associated with a reduction in AF recurrence after pulmonary vein isolation in diabetic patients [25, 61] and inhibitors of AGE formation have been shown to prevent atrial structural remodeling in diabetic rat models [22, 63]. The gene discussed is AGER; the disease is atrial fibrillation.